PRKN and prostate carcinoma: Several cancers did not appear to be affected at all, including glioblastomas, CLL, and prostate cancers, and many had very low frequency of deletions of CFS-like genes, including breast cancer, which showed PARK2 as its most frequently deleted CFS-like gene at just above 2% (Figure 8A).